Markus Warmuth
President & CEO, Director at Monte Rosa Therapeutics, Inc. (GLUE)
Markus Warmuth has filed 11 insider reports with the SEC since March 2022, as president & CEO and director at Monte Rosa Therapeutics, Inc. (GLUE). In the last 12 months Markus Warmuth sold $951K of stock on the open market. In the latest filing, on July 17, 2026, Markus Warmuth sold 9,500 shares of Monte Rosa Therapeutics, Inc. (GLUE) for $220K at an average of $23.18.
- Filings
- 11
- Companies
- 1
- Bought on market
- None
- Sold on market
- $951K
Companies where Markus Warmuth is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| President & CEO, Director | 585,038 | $951K | $8.91 | Jul 17, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jul 16, 2026-$220KGLUEPresident & CEO Warmuth Markus sold $220,219 worth of shares (9,500 units at $23.18), decreasing direct ownership by 2% to 585,038 unitsForm 4Open-market sale
- Jun 1, 2026-$106KGLUEPresident & CEO Warmuth Markus sold $106,253 worth of shares (5,466 units at $19.44) as part of a pre-agreed trading plan, decreasing direct ownership by 0.91% to 594,538 unitsForm 4Open-market sale10b5-1 plan
- May 1, 2026-$103KGLUEPresident & CEO Warmuth Markus sold $103,447 worth of shares (5,467 units at $18.92) as part of a pre-agreed trading plan, decreasing direct ownership by 0.90% to 600,004 unitsForm 4Open-market sale10b5-1 plan
- Apr 14, 2026-$141KGLUESEC Form 4 filed by Warmuth MarkusForm 4Open-market sale
- Mar 2, 2026-$98KGLUEPresident & CEO Warmuth Markus sold $97,974 worth of shares (5,466 units at $17.92), decreasing direct ownership by 0.88% to 613,471 unitsForm 4Open-market sale10b5-1 plan
- Jan 7, 2026-$128KGLUEPresident & CEO Warmuth Markus sold $128,373 worth of shares (5,466 units at $23.49), decreasing direct ownership by 0.88% to 618,937 unitsForm 4Open-market sale10b5-1 plan
- Jan 5, 2026-$154KGLUEPresident & CEO Warmuth Markus was granted 90,000 shares and sold $153,748 worth of shares (10,135 units at $15.17), increasing direct ownership by 15% to 624,403 unitsForm 4Grant or awardOpen-market sale
- Jan 2, 2025GLUEPresident & CEO Warmuth Markus was granted 128,000 shares, increasing direct ownership by 31% to 544,538 unitsForm 4Grant or award
- Jan 2, 2024GLUESEC Form 4 filed by Warmuth MarkusForm 4Grant or award
- Jan 3, 2023GLUESEC Form 4 filed by Warmuth MarkusForm 4Grant or award
- Mar 1, 2022GLUESEC Form 4 filed by Warmuth MarkusForm 4Grant or award
Compare Markus Warmuth with
- Markus Warmuth vs Jennifer Champoux1 shared
- Markus Warmuth vs Sharon Townson1 shared
- Markus Warmuth vs Ali Behbahani1 shared
- Markus Warmuth vs Filip Janku1 shared
- Markus Warmuth vs Anthony M. Manning1 shared
- Markus Warmuth vs Andrew N Schiff1 shared
Other insiders at the same companies
- Jennifer ChampouxGLUE
- Sharon TownsonGLUE
- Ali BehbahaniGLUE
- Filip JankuGLUE
- Anthony M. ManningGLUE
- Andrew N SchiffGLUE
- Jan SkvarkaGLUE
- Eric A HughesGLUE
- Kimberly BlackwellGLUE
- Christine SiuGLUE
- Edmund DunnGLUE
- Philip NicksonGLUE
- Matthew BowenGLUE
- Chandra P. LeoGLUE
Questions about Markus Warmuth
- What is Markus Warmuth's role at Monte Rosa Therapeutics, Inc.?
- Markus Warmuth reports to the SEC as president & CEO and director at Monte Rosa Therapeutics, Inc. (GLUE), according to the latest filing on July 17, 2026.
- How many shares does Markus Warmuth own?
- After the latest filing that states it, Markus Warmuth directly owned 585,038 shares of Monte Rosa Therapeutics, Inc. (GLUE). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Markus Warmuth bought or sold stock recently?
- The most recent open-market sale was on July 16, 2026: sold 9,500 shares of Monte Rosa Therapeutics, Inc. (GLUE) for $220K at an average of $23.18.
- How do I get alerts when Markus Warmuth files?
- Follow Markus Warmuth on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Markus Warmuth (SEC CIK 0001855643). Totals count each trade once, skipping amendments whose original is on file, from Mar 2, 2022 on. View on SEC EDGAR · Get this as JSON